Seer Inc Stock Today
| SEER Stock | USD 1.95 0.02 1.02% |
PerformanceVery Weak
| Odds Of DistressQuite High
|
Seer is selling at 1.95 as of the 16th of March 2025; that is 1.02 percent decrease since the beginning of the trading day. The stock's lowest day price was 1.94. Seer has more than 61 % chance of experiencing financial distress in the next few years of operation. It also generated negative returns for investors over the last 90 days. The performance scores are derived for the period starting the 16th of December 2024 and ending today, the 16th of March 2025. Click here to learn more.
Business Domain Pharmaceuticals, Biotechnology & Life Sciences | IPO Date 4th of December 2020 | Category Healthcare | Classification Health Care |
Seer, Inc., a life sciences company, engages in developing and commercializing products to decode the secrets of the proteome. Seer, Inc. was incorporated in 2017 and is headquartered in Redwood City, California. Seer Inc operates under Biotechnology classification in the United States and is traded on NASDAQ Exchange. The company has 55.74 M outstanding shares of which 1.93 M shares are at this time shorted by private and institutional investors with about 8.09 trading days to cover. More on Seer Inc
Moving together with Seer Stock
Moving against Seer Stock
| 0.66 | VRNA | Verona Pharma PLC Downward Rally | PairCorr |
| 0.57 | VALN | Valneva SE ADR Earnings Call This Week | PairCorr |
Follow Valuation Profit Patterns Odds of Bankruptcy
Check how we calculate scores
Seer Stock Highlights
| President,Treasurer CFO | David Horn | |||||||||||||||||||||||||||||||||||||||||||||||||||||||
| Business Concentration | Life Sciences Tools & Services, Pharmaceuticals, Biotechnology & Life Sciences, Health Care, NASDAQ Composite, NASDAQ Health Care, Health Care, Life Sciences Tools & Services, Biotechnology, Healthcare (View all Sectors) | |||||||||||||||||||||||||||||||||||||||||||||||||||||||
| Average Analyst Recommendation | ||||||||||||||||||||||||||||||||||||||||||||||||||||||||
Financial Strength
| ||||||||||||||||||||||||||||||||||||||||||||||||||||||||
Debt LevelsSeer can leverage the use of borrowed funds to amplify returns from an investment. In general, analyzing the relationship between debt to total assets helps investors to understand Seer's financial leverage. It provides some insight into what part of Seer's total assets is financed by creditors.
| ||||||||||||||||||||||||||||||||||||||||||||||||||||||||
Seer Inc (SEER) is traded on NASDAQ Exchange in USA. It is located in 3800 Bridge Parkway, Redwood City, CA, United States, 94065 and employs 134 people. Seer is listed under Life Sciences Tools & Services category by Fama And French industry classification. The company currently falls under 'Small-Cap' category with a current market capitalization of 116.57 M. Seer Inc conducts business under Life Sciences Tools & Services sector and is part of Health Care industry. The entity has 55.74 M outstanding shares of which 1.93 M shares are at this time shorted by private and institutional investors with about 8.09 trading days to cover.
Seer Inc currently holds about 451.19 M in cash with (46.11 M) of positive cash flow from operations. This results in cash-per-share (CPS) ratio of 7.21, which can makes it an attractive takeover target, given it will continue generating positive cash flow.
Check Seer Probability Of Bankruptcy
Ownership AllocationSeer Inc shows a total of 55.74 Million outstanding shares. Over half of Seer's outstanding shares are owned by institutional holders. These institutional holders are typically referred to as corporate investors that take positions in a given instrument to benefit from reduced trade commissions. Please note that no matter how many assets the company owns, if the real value of the company is less than the current market value, you may not be able to make money on it.
Check Seer Ownership Details
Seer Stock Institutional Holders
| Instituion | Recorded On | Shares | |
| Morgan Stanley - Brokerage Accounts | 2024-12-31 | 583.6 K | |
| Two Sigma Investments Llc | 2024-12-31 | 469.6 K | |
| Geode Capital Management, Llc | 2024-12-31 | 431.9 K | |
| Peapod Lane Capital Llc | 2024-12-31 | 428.9 K | |
| Citigroup Inc | 2024-12-31 | 389.6 K | |
| 1888 Investments, Llc | 2024-12-31 | 359.1 K | |
| Berkshire Asset Management Inc | 2024-12-31 | 275 K | |
| Amvescap Plc. | 2024-12-31 | 231.3 K | |
| Citadel Advisors Llc | 2024-12-31 | 230.2 K | |
| Softbank Group Corp | 2024-12-31 | 5.1 M | |
| Siren, L.l.c. | 2024-12-31 | 4 M |
Seer Historical Income Statement
Seer Stock Against Markets
Seer Corporate Management
| Marissa Dixon | Chief Officer | Profile | |
| Asim Siddiqui | Senior Development | Profile | |
| Martin Goldberg | Senior Development | Profile | |
| Kenny Ross | Chief Officer | Profile | |
| JD Esq | Chief Secretary | Profile | |
| Joe Laws | Chief CoFounder | Profile |
Additional Tools for Seer Stock Analysis
When running Seer's price analysis, check to measure Seer's market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy Seer is operating at the current time. Most of Seer's value examination focuses on studying past and present price action to predict the probability of Seer's future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move Seer's price. Additionally, you may evaluate how the addition of Seer to your portfolios can decrease your overall portfolio volatility.